Health related quality of life and symptoms after pelvic lymphadenectomy or radiotherapy vs. no adjuvant regional treatment in early-stage endometrial carcinoma: A large population-based study
- 31 October 2012
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 127 (1), 153-160
- https://doi.org/10.1016/j.ygyno.2012.06.007
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Long-Term Outcome and Quality of Life of Patients With Endometrial Carcinoma Treated With or Without Pelvic Radiotherapy in the Post Operative Radiation Therapy in Endometrial Carcinoma 1 (PORTEC-1) TrialJournal of Clinical Oncology, 2011
- Advances in the management of endometrial carcinomaGynecologic Oncology, 2011
- Lymphadenectomy for the management of endometrial cancerPublished by Wiley ,2010
- Quality of Life After Pelvic Radiotherapy or Vaginal Brachytherapy for Endometrial Cancer: First Results of the Randomized PORTEC-2 TrialJournal of Clinical Oncology, 2009
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2008
- Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical TrialJNCI Journal of the National Cancer Institute, 2008
- Impact of External Beam Adjuvant Radiotherapy on Health-Related Quality of Life for Long-Term Survivors of Endometrial Adenocarcinoma: A Population-Based StudyInternational Journal of Radiation Oncology*Biology*Physics, 2007
- The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer CenterGynecologic Oncology, 2006
- Routine pelvic lymphadenectomy in apparently early stage endometrial cancerEuropean Journal of Surgical Oncology, 2006
- Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trialThe Lancet, 2000